MedPath

四川依科制药有限公司

Ownership
-
Established
1999-02-03
Employees
-
Market Cap
-
Website
http://ykpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

115

NMPA:115

Drug Approvals

Ibuprofen Granules

Product Name
布洛芬颗粒
Approval Number
国药准字H20254259
Approval Date
May 27, 2025
NMPA

Desloratadine Tablets

Product Name
地氯雷他定片
Approval Number
国药准字H20253853
Approval Date
Apr 8, 2025
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20249295
Approval Date
Nov 5, 2024
NMPA

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20244957
Approval Date
Sep 19, 2024
NMPA

Valsartan Tablets

Product Name
缬沙坦片
Approval Number
国药准字H20244615
Approval Date
Aug 5, 2024
NMPA

Valsartan Tablets

Product Name
缬沙坦片
Approval Number
国药准字H20244616
Approval Date
Aug 5, 2024
NMPA

Pancreatin Enteric-coated Tablets

Product Name
胰酶肠溶片
Approval Number
国药准字H51020254
Approval Date
Jun 14, 2024
NMPA

Aminophylline Tablets

Product Name
氨茶碱片
Approval Number
国药准字H51020291
Approval Date
Jun 14, 2024
NMPA

参苓白术散

Approval Number
国药准字Z20053020
Approval Date
Jun 14, 2024
NMPA

Pancreatin Enteric-coated Tablets

Product Name
胰酶肠溶片
Approval Number
国药准字H51020255
Approval Date
Jun 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.